Describes a therapeutic approach being developed for the treatment of Alzheimer's disease (AD). Deliberate induction of an autoimmune response to amyloid-beta peptide, the constituent of neuritic plaques that is thought to cause the neurodegeneration and dementia in AD; Cause of the neuroinflammation in the AN-1792 trials.